Antenatal corticosteroid prophylaxis in women with increased sFlt-1/PlGF ratio in the clinical routine – A retrospective analysis

Read full text
Authors: Lisa Antonia Lorenz-Meyer, Max Hackelöer, Olivia Nonn, Caroline Scheele, Wolfgang Henrich, Stefan Verlohren
Cited by: 1
References: 25

Abstract

OBJECTIVES: The sFlt-1/PlGF ratio is a predictive biomarker for preeclampsia (PE)-related outcomes. In women with signs of PE at ≤34 weeks, it may guide the timing of antenatal corticosteroid (ACS) administration. METHODS: We retrospectively analyzed 702 women presenting with signs of PE and/or fetal growth restriction (FGR) between 22+0- and 33+6-weeks. High risk was defined as an sFlt-1/PlGF ratio ≥85. The predictive accuracy of the ratio for PE-related preterm birth at ≤34+0 weeks was assessed using receiver operating characteristic (ROC) analysis. Differences in remaining pregnancy duration and gestational age at delivery between risk groups were analyzed using the log-rank test (p

Fields of Study & Subjects

Pregnancy and preeclampsia studies Prenatal Screening and Diagnostics Systemic Lupus Erythematosus Research

Publication details

Journal / source
Journal of Perinatal Medicine
Publisher
Walter de Gruyter GmbH
Volume
54
Issue
3
Pages
533–542
Publication date
14 January 2026
Language
EN